Literature DB >> 33670746

Bioconjugation of a PNA Probe to Zinc Oxide Nanowires for Label-Free Sensing.

Teresa Crisci1,2, Andrea Patrizia Falanga3, Maurizio Casalino1, Nicola Borbone4, Monica Terracciano4, Giovanna Chianese1, Mariano Gioffrè1, Stefano D'Errico4, Maria Marzano5, Ilaria Rea1, Luca De Stefano1, Giorgia Oliviero3.   

Abstract

Zinc oxide nanowires (ZnONWs) are largely used in biosensing applications due to their large specific surface area, photoluminescence emission and electron mobility. In this work, the surfaces of ZnONWs are modified by covalent bioconjugation of a peptidic nucleic acid (PNA) probe whose sequence is properly chosen to recognize a complementary DNA (cDNA) strand corresponding to a tract of the CD5 mRNA, the main prognostic marker of chronic lymphatic leukemia. The interaction between PNA and cDNA is preliminarily investigated in solution by circular dichroism, CD melting, and polyacrylamide gel electrophoresis. After the immobilization of the PNA probe on the ZnONW surface, we demonstrate the ability of the PNA-functionalized ZnONW platform to detect cDNA in the μM range of concentration by electrical, label-free measurements. The specificity of the sensor is also verified against a non-complementary DNA sequence. These preliminary results highlight the potential application of PNA-bioconjugated ZnONWs to label-free biosensing of tumor markers.

Entities:  

Keywords:  DNA; PNA probe; ZnO nanowire; label-free biosensing; surface functionalization

Year:  2021        PMID: 33670746     DOI: 10.3390/nano11020523

Source DB:  PubMed          Journal:  Nanomaterials (Basel)        ISSN: 2079-4991            Impact factor:   5.076


  2 in total

Review 1.  Nucleic Acids as Biotools at the Interface between Chemistry and Nanomedicine in the COVID-19 Era.

Authors:  Nicola Borbone; Ilaria Piccialli; Andrea Patrizia Falanga; Vincenzo Piccialli; Giovanni N Roviello; Giorgia Oliviero
Journal:  Int J Mol Sci       Date:  2022-04-14       Impact factor: 6.208

2.  Exploring a peptide nucleic acid-based antisense approach for CD5 targeting in chronic lymphocytic leukemia.

Authors:  Elena Cesaro; Andrea Patrizia Falanga; Rosa Catapano; Francesca Greco; Simona Romano; Nicola Borbone; Arianna Pastore; Maria Marzano; Federico Chiurazzi; Stefano D'Errico; Gennaro Piccialli; Giorgia Oliviero; Paola Costanzo; Michela Grosso
Journal:  PLoS One       Date:  2022-03-31       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.